氩气高频电刀联合干扰素治疗尖锐湿疣疗效以及对淋巴细胞趋化因子和白细胞介素―17影响.docVIP

氩气高频电刀联合干扰素治疗尖锐湿疣疗效以及对淋巴细胞趋化因子和白细胞介素―17影响.doc

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
氩气高频电刀联合干扰素治疗尖锐湿疣疗效以及对淋巴细胞趋化因子和白细胞介素―17影响

氩气高频电刀联合干扰素治疗尖锐湿疣疗效以及对淋巴细胞趋化因子和白细胞介素―17影响   【摘要】目的:观察氩气高频电刀联合干扰素治疗尖锐湿疣的疗效以及对淋巴细胞趋化(LTN)因子和白细胞介素-17(IL-17)的影响。方法:将本院收治的尖锐湿疣患者96例参照数字法随机分为治疗组和对照组,两组各48例;对照组给予氩气高频电刀治疗,同时口服蒲地蓝消炎胶囊,3粒/次,4次/d;治疗组在对照组基础上采用重组人干扰素α-2b肌内注射治疗,1×106IU/d,3次/d;两组均连续治疗4周。分析两组治疗后临床疗效;比较两组不良反应和复发情况;检测两组血清LTN和IL-17。结果:治疗组患者临床总有效率为89.58%,对照组为66.67%,治疗组明显高于对照组(P0.05);对照组在治愈基础上有7例复发,治疗组复发3例,治疗组明显低于对照组(P0.05);治疗组治疗后2周和4周,患者血清LTN水平明显高于同期对照组,IL-17明显低于同期对照组,比较差异有统计学意义(P0.01)。结论:氩气高频电刀联合干扰素治疗尖锐湿疣的疗效显著,不良反应少,复发率低,提高患者血清LTN水平和降低血清IL-17水平可能与上述疗效相关。   【关键词】氩气高频电刀;干扰素;尖锐湿疣;淋巴细胞趋化因子;白细胞介素-17   Curative effect of argon high-frequency electrocautery combined with interferon in treating verruca acuminate and influences on lymphotactin and interleukin-17LI Guoquan1, DENG Yingjun1, NIE Guoneng1, CHEN Mingchun2. 1. Dermatology STD Department, Jiangmen Second People’s Hospital, Jiangmen 529030, Guangdong, China; 2. Dermatology STD Department, The Second Hospital Affiliated to Sun Yat-sen University, Guangzhou 510120, Guangdong, China   【Abstract】Objectives: To observe the curative effect of argon high-frequency electrocautery combined with interferon in treating verruca acuminate and influences on lymphotactin and interleukin-17. Methods: According to the random number table method, 96 patients with verruca acuminate in our hospital were randomly divided into control group (48 cases) and treatment group (48 cases). Patients in control group were orally treated by argon high-frequency electrocautery and Pudilan Xiaoyan capsule (3 capsules/time and q6h). On such basis, treatment group was treated by recombination interferon α2b by intramuscular injection (1×106IU/d, tid). The therapy courses were 4 weeks in both groups. Clinical effects were analyzed between both groups after treatment. Adverse reactions and recurrences were compared in two groups. Serum LTN and IL-17 were detected for both groups. Results: The total effective rate for treatment group was 89.58%, which was superior to control group of 66.67%(P0.05)

文档评论(0)

erterye + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档